Centhaquine

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Centhaquine 是一种肾上腺素能受体，可用于治疗术后疼痛和低血容量性休克的复苏。

Centhaquine is an adrenergic receptor potentially for the treatment of postoperative pain and for the resuscitation of hypovolemic shock.(In Vivo):Centhaquine (Centhaquin) (intravenous injection, 0.01-1.0 mg/kg; intraduodenal administration 1.0-2.5 mg/kg) lowers the blood pressure and reduced the heart rate of anaesthetized and unanaesthetized (decerebrate) cat in a dose-dependent manner.Centhaquine (Centhaquin) (intravertebral arterial injection; 5-10 μg) or by topical application to the exposed ventral surface of medulla or floor of the fourth ventricle causes hypotension and bradycardia as well as reduced the excitability of the vasomotor loci.Centhaquine (Centhaquin;PMZ-2010) (intravenous administration; 0.015mg/kg) can attenuate the deleterious effects of catecholamines, improving both the macro- and microcirculation during CPR.

——

——

Centhaquine,PMZ-2010

Others

Other Targets

Others

Others

Hypovolemic Shock

57961-90-7

331.45

C22H25N3

>98% (HPLC)

DMSO:60 mg/mL (181.02 mM; Need ultrasonic)

CC1=CC(=CC=C1)N1CCN(CCC2=NC3=CC=CC=C3C=C2)CC1

——

(-20℃)

With Ice Pack

≥ 2 years